International Pharmaceutical Aerosol Consortium on Regulation and Science

The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) is a global association of companies that develop and manufacture orally inhaled and nasal drug products (OINDP). Established in 2001, the consortium focuses on advancing the regulation and science of these products through collaborative research and interaction with global regulatory authorities such as the FDA and EMA. IPAC-RS provides a forum for members to develop consensus on technical and regulatory issues, contributing to the development of international standards and pharmacopeial guidance. Its activities are aimed at improving the quality, safety, and efficacy of inhalation and nasal therapies for patients worldwide. The organization is managed by professional staff and driven by the expertise of its member companies, which include leading pharmaceutical and medical device firms.